Remission of Schnitzler syndrome after treatment with anakinra.
Frischmeyer-Guerrerio
Pamela A
PA
Rachamalla
Radhika
R
Saini
Sarbjit S
SS
D000368:Aged; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D012074:Remission Induction; D019873:Schnitzler Syndrome / Q000175:diagnosis / Q000188:drug therapy*; D016896:Treatment Outcome
D018501:Antirheumatic Agents; D053590:Interleukin 1 Receptor Antagonist Protein